PET/CT Case Studies
Since opening in April 2000, New England PET Imaging System has provided PET and PET/CT services to patients with a variety of clinical needs in the areas of oncology, cardiology, and neurology.
We have attached a number of case studies for your review as well as specific cases focusing on Oncology, Cardiology and Neurology presented in the subpages listed above.
These case studies reflect the clinical questions addressed by FDG PET and the impact that PET and PET/CT can have in improved diagnosis and detection of disease, as well as in treatment planning and the monitoring of the disease process.
FDG PET and PET/CT Case Studies
18F-FDG PET/CT for Staging of Head and Neck Cancer—October 2012
18F-FDG PET/CT for Staging of Liver Cancer—July 2012
18F-FDG PET/CT for Evaluation/Staging of Mediastinal Mass—April 2012
18F-FDG PET/CT for Breast Cancer Staging and Restaging—January 2012
FDG-PET/CT Staging and Restaging of Small-Cell Lung Cancer—October 2011
FDG-PET/CT Plays a Key Role in Confirming Diagnosis of Large B-Cell Lymphoma—July 2011
FDG-PET/CT for Staging of Esophageal Cancer and Assessment of Response to Therapy—April 2011
FDG-PET/CT for Diagnosis and Staging of Lung Cancer—January 2011
PET/CT for Staging and Monitoring Response to Therapy in Breast Cancer—October 2010
PET/CT for Assessment of Lymphoma and Response to Chemotherapy—September 2010
Role of PET/CT in the Localization and
Staging of Head and Neck Squamous Cell Cancer—June 2010
Management of Colorectal Cancer and
Solitary Metastatic Lesion with FDG-PET/CT—March 2010
PET/CT’s Application in Radiation Oncology—September 2008
PET/CT for Detecting Recurrent Lymphoma—December 2006
FDG-PET for Metastatic Pancreatic Cancer—November 2006
FDG-PET for Detecting Brain Metastasis—June 2006
FDG-PET for Restaging Lymphoma—April 2006
FDG-PET for Metastatic Colon Cancer—January 2006
FDG-PET Detects Unknown Primary Head and Neck Cancer—November 2005
FDG-PET for Staging Lung Cancer—September 2005
FDG-PET for Metastatic Breast Cancer—August 2005
Focal-Intense FDG Uptake in Pseudotumor of the Lung—July 2005
FDG-PET for Staging Head and Neck Cancer—May 2005
Detection of Viable Myocardial Tissue—April 2005
FDG-PET for Cervical Cancer—March 2005
FDG-PET for Metastatic Melanoma—February 2005
PET for Early Diagnosis of Alzheimer's—October 2004
FDG PET for Seizure Focus—March 2004
18F-Sodium Fluoride (NaF) PET/CT Bone Scan Case Studies
CMS has recently approved coverage of 18F-Sodium Fluoride PET/CT bone scans. These case studies highlight the use of 18F-Sodium Fluoride (NaF) PET/CT bone scans. (Some of these Case studies courtesy of Siemens/PETNet.)
18F NaF Bone Scan Vs. 99mTc MDP Bone Scan For Staging A Patient With Prostate Cancer
18F NaF PET Imaging Vs. Planar 99mTc MDP In A Patient With Breast Cancer
18F NaF Bone Scan In A Patient With Lung Cancer And Skeletal Metastases |
